Your browser doesn't support javascript.
COVID-19 vaccination: the VOICE for patients with cancer.
van der Veldt, Astrid A M; Oosting, Sjoukje F; Dingemans, Anne-Marie C; Fehrmann, Rudolf S N; GeurtsvanKessel, Corine; Jalving, Mathilde; Rimmelzwaan, Guus F; Kvistborg, Pia; Blank, Christian U; Smit, Egbert F; Lemmens, Valery E E P; Hiltermann, T Jeroen N; Koopmans, Marion P G; Huckriede, Anke L W; Rots, Nynke Y; van Els, Cecile A C M; van Baarle, Debbie; Haanen, John B A G; de Vries, Elisabeth G E.
  • van der Veldt AAM; Department of Medical Oncology and Department of Radiology & Nuclear Medicine, Erasmus Medical Center-Cancer Institute, Rotterdam, the Netherlands.
  • Oosting SF; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Dingemans AC; Department of Respiratory Medicine, Erasmus Medical Center-Cancer Institute, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Fehrmann RSN; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • GeurtsvanKessel C; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Jalving M; Department of Medical Oncology, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Rimmelzwaan GF; Research Center for Emerging Infections and Zoonoses, University of Veterinary Medicine Hannover, Hannover, Germany.
  • Kvistborg P; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Blank CU; Department of Medical Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
  • Lemmens VEEP; Comprehensive Cancer Organization the Netherlands/Netherlands Cancer Registry, Utrecht, the Netherlands.
  • Hiltermann TJN; Department of Public Health, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Koopmans MPG; Department of Pulmonary Diseases, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • Huckriede ALW; Department of Viroscience, Erasmus Medical Center, Rotterdam, the Netherlands.
  • Rots NY; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
  • van Els CACM; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • van Baarle D; Center for Infectious Disease Control, National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
  • Haanen JBAG; Department of Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, the Netherlands.
  • de Vries EGE; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Nat Med ; 27(4): 568-569, 2021 04.
Article in English | MEDLINE | ID: covidwho-1085421

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Neoplasms Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01240-w

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccination / COVID-19 Vaccines / SARS-CoV-2 / COVID-19 / Neoplasms Type of study: Cohort study / Observational study / Prognostic study Topics: Vaccines Limits: Humans Language: English Journal: Nat Med Journal subject: Molecular Biology / Medicine Year: 2021 Document Type: Article Affiliation country: S41591-021-01240-w